Pfizer Begins Clinical Trial Of Coronavirus Vaccines In U.S. Plans To Have Millions Of Doses By October
In a news release, Pfizer said that the first cohort in the human trials was dosed last week in Germany as part of the BNT162 vaccine program. Participants in the trial will also be dosed at the New York University’s Grossman School of Medicine and the University of Maryland School of Medicine. Additionally, the University of Rochester Medical Center/Rochester Regional Health and Cincinnati Children’s Hospital Medical Center will begin enrolling trial participants....